Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study

Fig. 1

PLT count after administration of lusutrombopag

PLT levels are shown before, 1 week, 2 weeks and 4 weeks after the start of treatment, with peak values at 9 to 14 days, and the procedure should be scheduled to allow for that period. Once elevated, the PLT level decreases to the pre-dose level after 4 weeks

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us